SCHEMBL4093773

SCHEMBL4093773

COc1ccc(N2CCN(c3nc(-c4ccccc4)c(C(N)=O)s3)CC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
NPSR1 Q6W5P4 3/20 0.61
HTT P42858 3/20 0.61
ADORA3 P0DMS8 2/20 0.60
LMNA P02545 2/20 0.54
ALOX5 P09917 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
TP53 P04637 1/20 0.51
GAA P10253 2/20 0.50
KMT2A Q03164 1/20 0.50
CETP P11597 1/20 0.49
HPGD P15428 1/20 0.49
USP2 O75604 1/20 0.48
ADORA2A P29274 1/20 0.48
PTGS2 P35354 1/20 0.47
MAPT P10636 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
CDK8 P49336 1/20 0.47
CDK19 Q9BWU1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL347930 0.91 ALDH1A1 (0.63) ALDH1A1NPSR1HTTADORA3LMNA
SCHEMBL4086525 0.85 DHODH (0.59) ALDH1A1NPSR1HTTADORA3LMNA
SCHEMBL347552 0.83 PTGDR2 (0.62) ALDH1A1NPSR1HTTADORA3GAA
SCHEMBL347742 0.81 CA12 (0.55) ALDH1A1NPSR1HTTADORA3LMNA
SCHEMBL347743 0.81 CA12 (0.55) ALDH1A1NPSR1HTTADORA3LMNA
SCHEMBL348279 0.81 CETP (0.56) ALDH1A1NPSR1HTTADORA3LMNA
SCHEMBL4091068 0.81 ALDH1A1 (0.65) ALDH1A1NPSR1HTTADORA3LMNA
SCHEMBL4085482 0.81 AR (0.65) ALDH1A1NPSR1HTTADORA3LMNA
SCHEMBL4630926 0.80 DHODH (0.54) ALDH1A1NPSR1HTTADORA3LMNA
SCHEMBL27721066 0.80 ALDH1A1 (0.55) ALDH1A1NPSR1HTTADORA3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221604-A1 Thiazole Compounds and Their Use as PGD2 Antagonists ARGENTA DISCOVERY LIMITED (GB) 2009-09-03 US disclosed
EP-1922312-A1 THIAZOLE COMPOUNDS AND THEIR USE AS PGD2 ANTAGONISTS Argenta Discovery Limited (GB) 2008-05-21 EP disclosed
WO-2007028999-A1 THIAZOLE COMPOUNDS AND THEIR USE AS PGD2 ANTAGONISTS ARGENTA DISCOVERY LIMITED (GB) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221604-A1 Thiazole Compounds and Their Use as PGD2 Antagonists PTGDR2, PTGDR, PTGER2 ALDH1A1 3327/4885NPSR1 116/4885HTT 2735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.